| 000 | 01096 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515182321.0 | ||
| 264 | 0 | _c20090902 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1214-6994 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDusková, M | |
| 245 | 0 | 0 |
_aFinasteride treatment and neuroactive steroid formation. _h[electronic resource] |
| 260 |
_bPrague medical report _c2009 |
||
| 300 |
_a222-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a5-alpha Reductase Inhibitors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aFinasteride _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xmetabolism |
| 650 | 0 | 4 |
_aSteroids _xmetabolism |
| 700 | 1 | _aHill, M | |
| 700 | 1 | _aHanus, M | |
| 700 | 1 | _aMatousková, M | |
| 700 | 1 | _aStárka, L | |
| 773 | 0 |
_tPrague medical report _gvol. 110 _gno. 3 _gp. 222-30 |
|
| 999 |
_c19062625 _d19062625 |
||